Kathleen Laporte is Director of Precipio, Inc.. Currently has a direct ownership of 10,071 shares of PRPO, which is worth approximately $51,362. The most recent transaction as insider was on Apr 15, 2024, when has been sold 9,693 shares (Common Stock) at a price of $6.7 per share, resulting in proceeds of $64,943. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.1K
32.95% 3M change
n/a 12M change
Total Value Held $51,362

KATHLEEN LAPORTE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 15 2024
BUY
Grant, award, or other acquisition
$64,943 $6.7 p/Share
9,693 Added 49.04%
10,071 Common Stock
Sep 12 2023
BUY
Grant, award, or other acquisition
-
7,575 Added 50.0%
7,575 Common Stock

Also insider at

BOLT
Bolt Biotherapeutics, Inc. Healthcare
PBAXU
PHOENIX BIOTECH ACQUISITION CORP. Financial Services
ETNB
89bio, Inc. Healthcare
FIXX
Homology Medicines, Inc. Healthcare
KL

Kathleen Laporte

Director
New Haven, CT

Track Institutional and Insider Activities on PRPO

Follow Precipio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRPO shares.

Notify only if

Insider Trading

Get notified when an Precipio, Inc. insider buys or sells PRPO shares.

Notify only if

News

Receive news related to Precipio, Inc.

Track Activities on PRPO